BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 24844135)

  • 21. miR-214: a potential biomarker and therapeutic for different cancers.
    Sharma T; Hamilton R; Mandal CC
    Future Oncol; 2015; 11(2):349-63. PubMed ID: 25591843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs in the tumour microenvironment: big role for small players.
    Soon P; Kiaris H
    Endocr Relat Cancer; 2013 Oct; 20(5):R257-67. PubMed ID: 23878074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of exosomal miRNA on cancer biology and clinical applications.
    Sun Z; Shi K; Yang S; Liu J; Zhou Q; Wang G; Song J; Li Z; Zhang Z; Yuan W
    Mol Cancer; 2018 Oct; 17(1):147. PubMed ID: 30309355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of miRNAs in cell signaling of cancer associated fibroblasts.
    Eichelmann AK; Matuszcak C; Hummel R; Haier J
    Int J Biochem Cell Biol; 2018 Aug; 101():94-102. PubMed ID: 29807095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosome-derived miRNAs and ovarian carcinoma progression.
    Vaksman O; Tropé C; Davidson B; Reich R
    Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment.
    Conti I; Varano G; Simioni C; Laface I; Milani D; Rimondi E; Neri LM
    Cells; 2020 Jan; 9(1):. PubMed ID: 31952362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miRNA: the new gene silencer.
    Ross JS; Carlson JA; Brock G
    Am J Clin Pathol; 2007 Nov; 128(5):830-6. PubMed ID: 17951207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noncoding RNAs in molecular characterization of cancer preneoplasia.
    Wang W; Srivastava S
    Cancer Biomark; 2010; 9(1-6):133-40. PubMed ID: 22112473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal tumor-suppressive microRNAs as novel cancer therapy: "exocure" is another choice for cancer treatment.
    Kosaka N; Takeshita F; Yoshioka Y; Hagiwara K; Katsuda T; Ono M; Ochiya T
    Adv Drug Deliv Rev; 2013 Mar; 65(3):376-82. PubMed ID: 22841506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of microRNAs to Cancer Therapy].
    Iguchi H; Ochiya T
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):389-95. PubMed ID: 20332672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiRNAs in cancer: non-coding RNAs as appealing biomarkers for malignancy.
    Morin P
    Cancer Biomark; 2012; 11(6):227-8. PubMed ID: 23248179
    [No Abstract]   [Full Text] [Related]  

  • 33. MicroRNA expression signatures in solid malignancies.
    Galasso M; Sandhu SK; Volinia S
    Cancer J; 2012; 18(3):238-43. PubMed ID: 22647360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signaling by exosomal microRNAs in cancer.
    Falcone G; Felsani A; D'Agnano I
    J Exp Clin Cancer Res; 2015 Apr; 34(1):32. PubMed ID: 25886763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery.
    Principe S; Hui AB; Bruce J; Sinha A; Liu FF; Kislinger T
    Proteomics; 2013 May; 13(10-11):1608-23. PubMed ID: 23505015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.
    Wei J; Xie L; Taron M; Rosell R; Liu B
    Drug News Perspect; 2010 Dec; 23(10):655-61. PubMed ID: 21180651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The Functional Role of Exosomes in Cancer Biology and Their Potential as Biomarkers and Therapeutic Targets of Cancer].
    Naito Y; Yoshioka Y; Ochiya T
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):647-55. PubMed ID: 26199235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and prognostic microRNAs in stage II colon cancer.
    Schepeler T; Reinert JT; Ostenfeld MS; Christensen LL; Silahtaroglu AN; Dyrskjøt L; Wiuf C; Sørensen FJ; Kruhøffer M; Laurberg S; Kauppinen S; Ørntoft TF; Andersen CL
    Cancer Res; 2008 Aug; 68(15):6416-24. PubMed ID: 18676867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new role for microRNAs, as ligands of Toll-like receptors.
    Fabbri M; Paone A; Calore F; Galli R; Croce CM
    RNA Biol; 2013 Feb; 10(2):169-74. PubMed ID: 23296026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.